机构:[1]Department of Integrated TCM & Western Medicine, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting Road, Nanjing 210009, China[2]State Key Laboratory of Quality Research in Chinese Medicine & School of Pharmacy, Macau University of Science and Technology, Taipa, China[3]Department of Radiotherapy, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 55 Renmin South Road, 610041 Chengdu, Sichuan, China四川省人民医院四川省肿瘤医院[4]Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting Road, Nanjing 210009, China
This study was supported by the China Postdoctoral Science
Foundation (2018M632267) and the Project of Jiangsu
Administration of Traditional ChineseMedicine (YB2020099).
语种:
外文
PubmedID:
第一作者:
第一作者机构:[1]Department of Integrated TCM & Western Medicine, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting Road, Nanjing 210009, China
通讯作者:
推荐引用方式(GB/T 7714):
Yu Chen,Bao Ting-Ting,Jin Li,et al.HKDC1 Silencing Inhibits Proliferation and Glycolysis of Gastric Cancer Cells[J].Journal of oncology.2023,2023:3876342.doi:10.1155/2023/3876342.
APA:
Yu Chen,Bao Ting-Ting,Jin Li,Lu Jian-Wei&Feng Ji-Feng.(2023).HKDC1 Silencing Inhibits Proliferation and Glycolysis of Gastric Cancer Cells.Journal of oncology,2023,
MLA:
Yu Chen,et al."HKDC1 Silencing Inhibits Proliferation and Glycolysis of Gastric Cancer Cells".Journal of oncology 2023.(2023):3876342